Results 251 to 260 of about 152,498 (307)

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.

The Lancet HIV, 2014
T. A. Rasmussen, M. Tolstrup, C. Brinkmann, R. Olesen, C. Erikstrup, A. Solomon, A. Winckelmann, S. Palmer, C. Dinarello, M. Buzón, M. Lichterfeld, S. Lewin, L. Østergaard, O. Søgaard   +13 more
semanticscholar   +1 more source

Histone deacetylase inhibitor for NUT midline carcinoma

Pediatric Blood & Cancer, 2015
O. Maher, Anthony M. Christensen, Sireesha Yedururi, D. Bell, N. Tarek   +4 more
semanticscholar   +1 more source

Inhibitors of Histone-deacetylases

Tumori Journal, 2001
openaire   +3 more sources

INHIBITORS OF HISTONE DEACETYLASE

2008
DEZIEL ROBERT, LEIT SILVANA, BEAULIEU PATRICK, CHANTIGNY YVES ANDRE, MANCUSO JOHN, TESSIER PIERRE, SHAPIRO GIDEON, CHESWORTH RICHARD, SMIL DAVID   +8 more
  +19 more sources

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

Nature, 1998
Xin-Sheng Nan, H. Ng, Colin A. Johnson, C. D. Laherty, B. Turner, R. Eisenman, A. Bird   +6 more
semanticscholar   +1 more source

Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model.

Journal of Neuropathology and Experimental Neurology, 2013
Zhi-Yuan Zhang, H. Schluesener
semanticscholar   +1 more source

A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor‐β and vascular endothelial growth factor signalling

Liver international (Print), 2013
Yuqing Liu, Zhuo-Qing Wang, Jiani Wang, W. Lam, Shu-Qin Kwong, Furong Li, S. Friedman, Shuyan Zhou, Qi Ren, Zheng-Shuang Xu, Xin-Ge Wang, Ling Ji, Shoubin Tang, Hui Zhang, E. L. Lui, T. Ye   +15 more
semanticscholar   +1 more source

Histone deacetylase inhibitors

2009
BROWN MILTON L, JUNG MIRA O, DRITSCHILO ANATOLY, KONG YALI   +3 more
  +9 more sources

Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor

Cancer Chemotherapy and Pharmacology, 2013
M. Iwamoto, E. Friedman, Punam Sandhu, N. Agrawal, E. Rubin, J. Wagner   +5 more
semanticscholar   +1 more source

Histone deacetylase inhibitors: discovery and development as anticancer agents

Expert Opinion on Investigational Drugs, 2005
Milos Dokmanovic, Paul Marks
exaly